Gilead Sciences, Inc. (NASDAQ:GILD) announced interim results from a single-arm, open-label Phase 2 study evaluating GS-9973, an investigational oral inhibitor of spleen tyrosine kinase (Syk), for the treatment of patients with relapsed or refractory hematologic malignancies. Gilead Sciences, Inc. (NASDAQ:GILD) shares after opening at $75.67 moved to $76.20 on last trade day and at the end of the day closed at $72.07. Company price to sales ratio in past twelve months was calculated as 9.87 and price to cash ratio as 51.86. Gilead Sciences, Inc. (NASDAQ:GILD) showed a negative weekly performance of -3.97%.
Citigroup Inc. (NYSE:C) Exceeds Fed Minimum Capital Level under Stress Scenario. Citigroup Inc. (NYSE:C) shares fell -0.28% in last trading session and ended the day on $50.08. C return on equity ratio is recorded as 8.60% and its return on assets is 0.90%. Citigroup Inc. (NYSE:C) yearly performance is 10.82%.
AT&T Inc. (NYSE:T) has strongly criticized Netflix, Inc. (NFLX) for arguing that its network should be linked free of cost by Internet Service Providers (ISPs). AT&T has termed this an “arrogant proposition” and claims that it is a convenient way for video streaming companies such as Netflix to pass on costs to ISPs. AT&T Inc. (NYSE:T) shares moved up 0.62% in last trading session and was closed at $34.30, while trading in range of $34.13 – $34.80. AT&T Inc. (NYSE:T) year to date (YTD) performance is -1.15%.
Intel Corporation (NASDAQ:INTC) flaunts 8-core Extreme Edition Haswell with support for DDR4 memory. Intel Corporation (NASDAQ:INTC) has lifted the suspense over its 2014 official road-map, which should certainly get many enthusiasts excited about the brand. Intel Corporation (NASDAQ:INTC) weekly performance is 2.73%. On last trading day company shares ended up $25.17. Intel Corporation (NASDAQ:INTC) distance from 50-day simple moving average (SMA50) is 1.68%. Analysts mean target price for the company is $25.05.
Leave a Reply